Image-derived biomarkers and multimodal imaging strategies for lung cancer management (Q38312373)

2 September 2017

1 reference

title

Image-derived biomarkers and multimodal imaging strategies for lung cancer management (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

Christina Pfannenberg

5

object named as

Christina Pfannenberg

0 references

Alexander W Sauter

object named as

Alexander W Sauter

1

0 references

author name string

Nina Schwenzer

2

1 reference

2 September 2017

Mathew R Divine

3

1 reference

2 September 2017

Bernd J Pichler

4

1 reference

2 September 2017

Christina Pfannenberg

5

1 reference

2 September 2017

9 January 2015

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

2 September 2017

1 reference

2 September 2017

42

1 reference

2 September 2017

4

1 reference

2 September 2017

634-643

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-014-2974-5

2 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Advances in oncologic imaging: update on 5 common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Management of non-small-cell lung cancer: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

The transcriptional landscape and mutational profile of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Preoperative staging of lung cancer with combined PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Preoperative PET and the reduction of unnecessary surgery among newly diagnosed lung cancer patients in a community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Mediastinal lymph node staging: from noninvasive to surgical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Bronchogenic carcinoma: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Generating evidence for clinical benefit of PET/CT in diagnosing cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Diffusion-weighted imaging vs STIR turbo SE imaging: capability for quantitative differentiation of small-cell lung cancer from non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Key factors in the acquisition of contrast kinetic data for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Classic models for dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Application of CT in the investigation of angiogenesis in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Assessment of tumor vascularity in lung cancer using volume perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Combined PET/MRI: one step further in multimodality imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

PET of signal transduction pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Relevance of incidental colorectal FDG-PET/CT-enhanced lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

PET of EGFR expression with an 18F-labeled affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Lung cancer: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

The tumor microenvironment in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Implementation of hypoxia imaging into treatment planning and delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Blood flow-metabolism mismatch: good for the tumor, bad for the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2974-5

Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging

21 January 2018

1 reference

12 December 2020

Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin

1 reference

12 December 2020

Combined PET/MR imaging--technology and applications

1 reference

12 December 2020

Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

1 reference

12 December 2020

Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.

1 reference

12 December 2020

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system

1 reference

12 December 2020

Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung

1 reference

12 December 2020

The revised TNM staging system for lung cancer.

1 reference

12 December 2020

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

12 December 2020

Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy

1 reference

12 December 2020

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer

1 reference

12 December 2020

Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung

1 reference

12 December 2020

Performance assessment of dynamic spiral scan modes with variable pitch for quantitative perfusion computed tomography.

1 reference

12 December 2020

10.1007/S00259-014-2974-5

Identifiers

DOI

1 reference

release_2oubtcef5fazrbqsdyzpiooquq

2 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2oubtcef5fazrbqsdyzpiooquq

24 November 2022

mapped directly with Wikidata item

1 reference